You made it through acute withdrawal. The worst is behind you. Then somewhere between week 2 and month 2, you might notice things still aren’t quite right. Sleep is broken. Mood swings out of nowhere. You can’t focus. You feel flat, then anxious, then fine, then exhausted.
Or you might feel mostly fine. Sleeping well. Energy back. Some lingering blahness here and there but generally good. Both are normal. This page is to help you understand what’s happening either way.
If what you’re feeling right now is more than fine, clear, optimistic, energized, almost euphoric, that’s the pink cloud, and it has its own page on how to use the window and what tends to come after.
PAWS: definition and scope
PAWS, post-acute withdrawal syndrome, is the cluster of psychological, mood, sleep, and cognitive symptoms that can persist after acute physical withdrawal ends. The construct is recognized in SAMHSA’s TIP-45 detoxification guidance and described as the “second-phase” of withdrawal in a substantial body of peer-reviewed addiction literature. It’s not exclusive to opioids, alcohol, benzodiazepine, and stimulant PAWS are all documented, but the opioid version is what concerns this site.
Not everyone gets PAWS. Reported prevalence varies enormously depending on what’s measured and how “PAWS” is operationalized, and plenty of people in this community bounced back within weeks of acute ending without significant PAWS at all. If that’s you, you don’t need to be looking for symptoms that aren’t there.
For people who do get PAWS, severity and duration vary. Factors that appear to influence it:
- How long you were using and at what dose
- Which compound (7-OH alone vs. stacked synthetics like MGM-15 or pseudo)
- Genetics, baseline mental health, sleep quality, support system
- Lifestyle: nutrition, exercise, stress, connection
The range: some people feel close to normal within 2 to 4 weeks of acute ending. Some have lingering low-grade symptoms for months. Most are somewhere in between. None of those outcomes is wrong. Don’t compare your timeline to someone else’s.
Timeline (with the variance caveat)
The shape below is for people who experience meaningful PAWS. If you’re not, ignore this.
- Weeks 2 to 6: if PAWS is going to show up, this is usually when. Sleep disruption, anhedonia, mood swings. For some, this stretch is mild and brief.
- Weeks 6 to 12: symptoms cycle. Good days and bad days mixed. This is when most people who hit walls hit them, because the novelty of being clean has worn off.
- Months 3 to 6: for most, symptoms become less frequent. Sleep starts improving. Pleasure starts coming back, in small doses at first.
- Months 6 to 12: for the people who had longer PAWS, symptoms typically fade significantly. Some people report PAWS-type symptoms surfacing under stress for a year or longer, but the intensity drops dramatically over time.
Most people coming off 7-OH alone do not have prolonged PAWS. People who were on stacked synthetics, MGM-15, MIT-A, or pseudo for extended periods are more likely to. Your specific situation matters more than averages.
Symptoms
You may have some, all, or none of these:
- Sleep disruption. Trouble falling asleep, broken sleep, vivid dreams, fatigue that sleep doesn’t fix. See Sleep Recovery for the focused page.
- Anhedonia and depression. Things that used to feel good (food, music, sex, hobbies) feel muted or empty. See Depression and Anhedonia for the focused page on these symptoms, or Dopamine Recovery for the deeper neurobiology.
- Mood swings. Sometimes within hours.
- Anxiety. Often free-floating, not attached to anything specific. The acute “something terrible is about to happen” version of this is covered separately at Impending Doom.
- Cognitive fog. Memory glitches, slower processing, trouble focusing.
- Low motivation and energy.
- Cravings. Often triggered by stress, environments, or seemingly nothing. If a craving is loud right now, Thinking About Using? is the page to read.
- Stress sensitivity. Things that wouldn’t have rattled you before feel huge.
- Physical symptoms. Lingering muscle tension, occasional restless legs.
- Hormonal / endocrine effects. Low libido, sexual dysfunction, menstrual cycle changes, body composition shifts, persistent fatigue that overlaps with the other PAWS symptoms but tracks the body’s hormone systems specifically. Chronic opioid-receptor activation suppresses the HPG and HPA axes; recovery generally happens but takes weeks to months. See Endocrine Recovery After 7-OH and Kratom for the full picture, testing options, and what to expect for both men and women.
If you’re getting good sleep, your mood is steady, and you feel mostly like yourself, that’s a real outcome and it’s becoming more common as people use better tools earlier in recovery. This page is for the people who do hit rough patches; if you’re not, enjoy it.
The neurobiology, briefly
Chronic opioid exposure produces measurable changes in the brain that take time to unwind:
- Mu-opioid receptor adaptation. Chronic agonist exposure produces receptor downregulation and altered signaling; the system needs time to recalibrate after exposure stops.
- HPA axis dysregulation. The stress-response system is persistently altered by chronic opioid use, which contributes to the stress-sensitivity, mood lability, and sleep disruption that define early PAWS.
- Dopamine system effects. Imaging research shows reduced dopamine receptor availability and altered reward processing in long-term opioid use that recovers over weeks to months, covered on the Dopamine Recovery page.
- Sleep architecture. REM and deep sleep are suppressed by chronic opioid use and rebound during recovery, which is part of why early sleep is vivid, broken, and unrefreshing even when total sleep time looks normal.
This is the system rebuilding what it outsourced. The discomfort is real, time-limited, and part of a process that ends.
Those persistent adaptations are also why a return to use can re-trigger withdrawal faster than your first quit did. For the picture of how re-exposure interacts with the unfinished healing, see Will One Use Bring Withdrawal Back? (Kindling).
Windows and waves
For people who do experience PAWS, the most important pattern to understand is that it’s not linear. You don’t get steadily better day by day. You cycle through “windows” (good days, sometimes whole good weeks where you feel almost normal) and “waves” (bad days where it feels like everything regressed).
Symptoms often cycle in this windows-and-waves pattern. When you’re in a window, you may think you’re done. Then a wave hits and you panic that you’ve gone backward. You haven’t. Waves get less frequent, less intense, and shorter over time. The windows get longer.
When a wave hits, recognize it for what it is, ride it out, and trust that the next window is coming. Don’t make big life decisions in a wave.
Normal vs. concerning
Use this to calibrate.
Normal during PAWS:
- Anhedonia, flat mood, low motivation, especially weeks 2 to 12
- Sleep disruption that improves gradually over months
- Vivid dreams (sometimes nightmares about using)
- Mood swings, irritability, free-floating anxiety
- Cognitive fog, slow processing
- Occasional cravings, especially under stress
- A wave at month 4 that feels like regression. It isn’t.
Worth a call to a prescriber:
- Depression that’s deep, persistent, and not improving over weeks
- Anxiety that’s stopping you from functioning
- Sleep deprivation severe enough to affect physical health
- Symptoms that feel beyond what you can handle
Worth an ER or 988 call right now:
- Any thoughts of suicide or self-harm
- A plan for hurting yourself
- Inability to keep yourself safe
Crisis numbers live on Crisis Hotlines and in the Crisis button on every page.
Interventions
Interventions cluster into three tiers, evidence-based, clinically used, and community-discussed, plus a list of things to avoid. This page gives the overview; the focused pages own the detail.
Evidence-based
The non-medication interventions with peer-reviewed support:
| Intervention | What it does | Source |
|---|---|---|
| Aerobic exercise | 20-30 min of cardio, 4-5 days/week. Increases BDNF, lifts mood, reduces craving intensity. Strongest single non-medication intervention. | Szuhany et al., meta-analysis (29 studies) |
| Sleep optimization | Bad sleep amplifies every other PAWS symptom. Consistent schedule, dark/cool room, morning sunlight. | Sleep Recovery for the focused page |
| CBT | Most-studied behavioral intervention for substance use disorders. | Magill et al., CBT for SUD review |
| Morning sunlight | 10-15 min within an hour of waking. Resets circadian rhythm. | Circadian light exposure review |
| Social contact | Isolation prolongs PAWS. Mutual aid, SMART Recovery, in-person contact. | SAMHSA recovery support |
| Protein and stable blood sugar | Skipping meals and high-sugar swings amplify mood lability. | General nutrition guidance |
Clinically used (prescribed)
Prescribers use a recognizable set of medications for PAWS-adjacent symptoms: SSRIs/SNRIs (persistent depression/anxiety), bupropion (anhedonia, low motivation), gabapentin (anxiety, sleep, restless legs), clonidine (stress reactivity, sleep), trazodone (sleep), mirtazapine (sleep, anxiety, depression, nausea, single-med coverage), buspirone (anxiety without dependence), low-dose naltrexone (post-acute only, can’t combine with bupe), and continued MAT, buprenorphine via the Sublocade single-shot exit, or SR-17 as the second community-validated medication-assisted path off the synthetics.
For what each does, when it’s used, dosing context, and the interaction profile: Helper Medications is the primary page. For getting a prescriber, see Telehealth Providers.
Community-discussed (limited evidence)
Supplements that come up in recovery forums for PAWS symptoms include magnesium, L-tyrosine, omega-3, vitamin D, B-complex, NAC, L-theanine, glycine, ashwagandha, and rhodiola. Evidence is limited for all of these in the post-opioid recovery context specifically. Most are low-risk but several have real interaction profiles (L-tyrosine with MAOIs, ashwagandha with hyperthyroidism, serotonergic interactions with SSRIs).
Vitamins & Supplements is the primary page, full breakdown by symptom, the interaction profiles, and the practical “don’t stack everything at once” guidance.
Peptides (Selank for anxiety, Semax for cognition, DSIP for sleep) come up in PAWS contexts and are covered honestly on Peptides for Opioid Withdrawal: what the evidence supports per peptide, the supply-chain and injection-safety considerations, and how the cost compares to evidence-based alternatives. None have been studied specifically for PAWS.
Things to avoid
- Stimulant misuse to push through anhedonia. Adderall without a prescription, high-dose caffeine, energy-drink cycles. Pushes a depleted system in the wrong direction.
- Alcohol for sleep or anxiety. Wrecks sleep architecture and is its own dependence vector.
- Heavy cannabis use. Has its own dependence profile and prolongs sleep architecture recovery for some people. See Cannabis and THC in Recovery for the two-sided treatment of cannabis use during recovery.
- Phenibut, kava, kratom-extract products marketed as “natural.” These are how people who’ve quit one dependence end up in another.
- “Dopamine fasting” / extreme abstinence protocols. The underlying behavioral practice may help; the dopamine framing is wrong and the extreme versions backfire, see Dopamine Recovery for the longer treatment of why this framing falls apart.
If you’re on Suboxone, your PAWS picture is different
A lot of people in this community use Suboxone (or did) as a short-term taper tool. If you’re currently on bupe, the PAWS picture above doesn’t quite map to your experience, and it’s worth understanding why.
Bupe blunts the healing while it’s working
Buprenorphine is a partial mu-opioid receptor agonist. While you’re on it, your receptors are still being activated. That’s the whole point, it’s why bupe suppresses cravings and withdrawal. But it also means your brain isn’t fully rebuilding the way it would if you were opioid-free. Endogenous endorphin production stays suppressed. Receptor recovery is partial. Some of the brain healing PAWS represents is on pause.
This isn’t a reason not to use bupe. It’s a reason to understand that the PAWS clock effectively starts when your taper ends, not when your acute withdrawal from 7-OH ended. If you taper off bupe at week 8 of your recovery, expect PAWS-style symptoms in the weeks after, not “I’m 8 weeks clean and should be over this by now.”
Some symptoms people attribute to PAWS are bupe side effects
While on bupe, you may experience:
- Emotional blunting and flat affect
- Anhedonia and low motivation
- Low libido
- Sleep disturbances
- Fatigue
- Sweating, especially at night
These are documented long-term Suboxone effects, not necessarily PAWS. The distinction matters because the fix is different. If it’s PAWS, time and lifestyle interventions help. If it’s bupe-related, lowering the dose or completing the taper is what helps. See Long-Term Suboxone Risks for the deeper dive.
If you’ve been on bupe for months and you’re feeling consistently flat, blunted, or “fine but not really”, that’s likely the medication, not unhealing brain chemistry. Talk to your prescriber about whether your dose is higher than it needs to be.
Symptoms bupe doesn’t address
Suboxone covers the opioid receptor side of things. It does not address:
- The serotonergic and adrenergic piece, direct receptor activity from minor alkaloids like paynantheine, speciogynine, and corynantheidine (León et al., J Med Chem 2021; Obeng et al., J Med Chem 2020). The wired anxiety, brain zaps, and broken sleep that don’t lift on bupe are usually this. See Why Suboxone Might Not Be Working.
- The dopamine/reward system rebuild, see Dopamine Recovery.
- The behavioral and habit patterns.
- Sleep architecture changes.
Adjuncts (clonidine, gabapentin, trazodone, magnesium, L-theanine) can help these gaps while you’re on bupe. Most of the lifestyle interventions in this post still apply: exercise, sleep hygiene, nutrition, sunlight, connection.
LDN and bupe don’t mix
Low-dose naltrexone cannot be taken while on bupe. LDN is a partial opioid antagonist; bupe is a partial agonist. They fight at the receptor and you’ll get precipitated withdrawal. LDN is a tool for after you’ve fully tapered off bupe and waited the full washout period (typically 7 to 14 days). See Low-Dose Naltrexone.
The trade-off, plainly
For most people, bupe is a powerful tool that gets them off 7-OH safely with minimal acute suffering. The trade-off is that the brain healing happens after the bupe taper, not during it. Understanding this prevents the common pattern of “I’m on bupe and I still feel flat, what’s wrong?” The answer is often: nothing’s wrong, that’s bupe, and the real recovery curve starts when you finish the taper.
You’re not broken. You’re rebuilding.
For some people, recovery from 7-OH is genuinely smooth. For others, PAWS is a real and uncomfortable phase. Both are normal. Neither is a sign you did something wrong.
If you’re in the smooth-recovery group: enjoy it, keep your routines, don’t get complacent.
If you’re in the PAWS group: your brain is healing. Receptors are recovering. Endorphin production is rebuilding. The work you do here, the supplements you consider, the routines you build, the connections you maintain, all of it adds up.
Where to read next
- The Pink Cloud: the early-recovery upside some people hit after acute eases. Calibrated for “what to do with this energy” rather than “wait for it to fade.”
- Depression and Anhedonia: the focused page on the flat-mood and can’t-feel-pleasure side of PAWS.
- Dopamine Recovery: the dopamine side specifically: what’s happening, what helps, what’s pop-neuroscience.
- Sleep Recovery: sleep is the longest tail; the focused page.
- Impending Doom: the specific terror that hits in withdrawal and PAWS, and what to do with it.
- Will One Use Bring Withdrawal Back? (Kindling): what happens if you use again after a stretch off.
- Long-Term Outlook: what recovery looks like over the coming months.
- Thinking About Using?: bookmark for craving moments.
- Telehealth Providers: for the SSRI / SNRI / bupropion / buspirone / Suboxone / Sublocade items in the clinically-used list. LDN sits outside standard OUD telehealth; see the LDN page for that routing. SR-17 is off-prescription.